331
Participants
Start Date
December 31, 2009
Primary Completion Date
September 30, 2011
Study Completion Date
September 30, 2011
SABER-Bupivacaine
Injectable Extended Release Solution; SABER-Bupivacaine /Once
Bupivacaine HCl
Injectable Solution; Bupivacaine HCl /Once
SABER-Placebo
Injectable Solution; SABER-Placebo/Once
DURECT Study Site, Box Hill
DURECT Study Site, Ringwood East
DURECT Study Site, Woodville South
DURECT Study Site, Christchurch
DURECT Study Site, New York
DURECT Study Site, Hershey
DURECT Study Site, Durham
DURECT Study Site, Powder Springs
DURECT Study Site, Tampa
DURECT Study Site, Birmingham
DURECT Study Site, Florence
DURECT Study Site, Sheffield
DURECT Study Site, Montgomery
DURECT Study Site, Mobile
DURECT Study Site, Mobile
DURECT Study Site, Columbus
DURECT Study Site, Indianapolis
DURECT Study Site, Troy
DURECT Study Site, Duluth
DURECT Study Site, Houston
DURECT Study Site, Temple
DURECT Study Site, Arcadia
DURECT Study Site, Pasadena
DURECT Study Site, Fontana
DURECT Study Site, Laguna Hills
DURECT Study Site, Boston